EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro

Ioanna A Anastasiou iD, Anastasios Tentolouris, Panagiotis Sarantis iD, Athanasia Katsaouni iD, Eleni Rebelos, Iordanis Mourouzis, Constantinos Pantos, Nikolaos Tentolouris iD

Pharmaceutics · 27.08.2025 · 17 (9) · 1115

DOI: 10.3390/pharmaceutics17091115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 27.08.2025. Verfasst von Ioanna A Anastasiou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Propaedeutic Internal Medicine, 'Laiko' General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens,…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Account for Research Grants of the National and Kapodistrian University of Athens, Athens, Greece.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Glucagon-like peptide-1 (GLP-1) is an endogenous hormone with receptors widely expressed across multiple organs. GLP-1 receptor agonists (GLP-1RAs), primarily used for diabetes management, have demonstrated anti-inflammatory and antioxidant properties beyond glucose regulation. This study explores the protective effect of semaglutide, a GLP-1RA, in reducing oxidative stress and promoting wound healing in human dermal fibroblasts. Additionally, it assesses whether semaglutide offers the direct protection of retinal endothelial cells under oxidative stress.

Methods

Human dermal fibroblasts and retinal endothelial cells were treated with semaglutide at concentrations ranging from 0 to 45 pg/mL for 24 h under oxidative stress induced by hydrogen peroxide (H2O2). Cell viability and ATP levels were measured via MTT and ATP assays. Apoptosis was evaluated using propidium iodide staining. Intracellular reactive oxygen species (ROS) and mitochondrial superoxide were assessed through confocal microscopy with specific fluorescent probes. Wound healing was tested using scratch assays, with closure monitored over time and quantified with ImageJ (version 1.51). Gene expression levels of antioxidants, extracellular matrix components, inflammatory cytokines, and MMPs (MMP3, MMP9) were determined via real-time PCR.

Results

Semaglutide significantly improved cell viability and ATP production under oxidative stress (p < 0.001), while reducing apoptosis and intracellular ROS levels. It notably accelerated fibroblast wound closure, achieving near-complete restoration. Gene analysis revealed increased expression of antioxidant and ECM-related genes, along with decreased pro-inflammatory cytokines and MMPs, indicating reduced inflammation and enhanced tissue remodeling.

Conclusions

Semaglutide offers robust antioxidative and cytoprotective effects in dermal fibroblasts and retinal endothelial cells, promoting wound healing. These findings highlight its therapeutic potential for diabetic foot ulcers and diabetic retinopathy, supporting further in vivo investigation.

Schlagwörter

Stichwörter der Autor:innen

cellular regenerationdiabetic complicationsoxidative stresssemaglutidewound healing

Autor:innen und Institutionen

  • Department of Propaedeutic Internal Medicine, 'Laiko' General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Ioanna A Anastasiou, Panagiotis Sarantis, Athanasia Katsaouni, Nikolaos Tentolouris

Förderung

  • Special Account for Research Grants of the National and Kapodistrian University of Athens, Athens, Greece

Zitieren

APA

Anastasiou, I. A., Tentolouris, A., Sarantis, P., Katsaouni, A., Rebelos, E., Mourouzis, I., Pantos, C., & Tentolouris, N. (2025). Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro. Pharmaceutics, 17(9), 1115. https://doi.org/10.3390/pharmaceutics17091115

Vancouver

Anastasiou IA, Tentolouris A, Sarantis P, Katsaouni A, Rebelos E, Mourouzis I, et al. Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro. Pharmaceutics. 2025;17(9):1115. doi:10.3390/pharmaceutics17091115

BibTeX
@article{Anastasiou2025,
  author = {Anastasiou, Ioanna A and Tentolouris, Anastasios and Sarantis, Panagiotis and Katsaouni, Athanasia and Rebelos, Eleni and Mourouzis, Iordanis and Pantos, Constantinos and Tentolouris, Nikolaos},
  title = {Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1115},
  doi = {10.3390/pharmaceutics17091115}
}
Kostenlos starten →